<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
   <journal-meta>
      <journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
      <journal-id journal-id-type="publisher-id">plos</journal-id>
      <journal-id journal-id-type="pmc">plosone</journal-id>
      <journal-title-group>
         <journal-title>PLoS ONE</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1932-6203</issn>
      <publisher>
         <publisher-name>Public Library of Science</publisher-name>
         <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher>
   </journal-meta>
   <article-meta>
      <article-id pub-id-type="publisher-id">PONE-D-12-40359</article-id>
      <article-id pub-id-type="doi">10.1371/journal.pone.0062723</article-id>
      <article-categories>
         <subj-group subj-group-type="heading">
            <subject>Research Article</subject>
         </subj-group>
<subj-group subj-group-type="Discipline-v2"><subject>Biology</subject>
<subj-group>
<subject>Anatomy and physiology</subject>
<subj-group>
<subject>Ocular system</subject>
<subj-group>
<subject>Ocular anatomy</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject>
<subj-group>
<subject>Anatomy and physiology</subject>
<subj-group>
<subject>Ocular system</subject>
<subj-group>
<subject>Ocular anatomy</subject>
</subj-group>
</subj-group>
</subj-group>
<subj-group>
<subject>Clinical research design</subject>
<subj-group>
<subject>Meta-analyses</subject>
</subj-group>
</subj-group>
<subj-group>
<subject>Ophthalmology</subject>
<subj-group>
<subject>Glaucoma</subject>
</subj-group>
</subj-group>
<subj-group>
<subject>Radiology</subject>
<subj-group>
<subject>Diagnostic radiology</subject>
<subj-group>
<subject>Ultrasonography</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
      </article-categories>
      <title-group>
         <article-title>Color Doppler Imaging Analysis of Retrobulbar Blood Flow Velocities in Primary Open-Angle Glaucomatous Eyes: A Meta-Analysis</article-title>
         <alt-title alt-title-type="running-head">Meta-Analysis on CDI in POAG</alt-title>
      </title-group>
      <contrib-group>
         <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western"><surname>Meng</surname>
<given-names>Nana</given-names>
            </name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
         </contrib>
         <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western"><surname>Zhang</surname>
<given-names>Ping</given-names>
            </name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
         </contrib>
         <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western"><surname>Huang</surname>
<given-names>Huadong</given-names>
            </name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
         </contrib>
         <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western"><surname>Ma</surname>
<given-names>Jinlan</given-names>
            </name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
         </contrib>
         <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western"><surname>Zhang</surname>
<given-names>Yue</given-names>
            </name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
         </contrib>
         <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western"><surname>Li</surname>
<given-names>Hao</given-names>
            </name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
         </contrib>
         <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western"><surname>Qu</surname><given-names>Yi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref>
         </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label><addr-line>Department of Health Care, Qilu Hospital of Shandong University, Jinan, China</addr-line></aff>
      <aff id="aff2"><label>2</label><addr-line>Department of Ophthalmology, Qihe Country Hospital, Qihe, China</addr-line></aff>
      <contrib-group>
         <contrib contrib-type="editor" xlink:type="simple">
            <name name-style="western"><surname>Mori</surname>
<given-names>Keisuke</given-names>
            </name><role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
         </contrib>
      </contrib-group>
      <aff id="edit1"><addr-line>Saitama Medical University, Japan</addr-line></aff>
      <author-notes>
         <corresp id="cor1">* E-mail: <email xlink:type="simple">drquyi@gmail.com</email></corresp>
         <fn fn-type="conflict">
            <p>The authors have declared that no competing interests exist.</p>
         </fn>
         <fn fn-type="con">
            <p>Collection and management of the data: NM PZ HH JM YZ HL YQ. Conceived and designed the experiments: NM YQ. Analyzed the data: NM YQ. Contributed reagents/materials/analysis tools: PZ HH. Wrote the paper: NM YQ.</p>
         </fn>
      </author-notes>
      <pub-date pub-type="collection">
         <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
         <day>13</day>
         <month>5</month>
         <year>2013</year>
      </pub-date>
      <volume>8</volume>
      <issue>5</issue>
      <elocation-id>e62723</elocation-id>
      <history>
         <date date-type="received">
            <day>19</day>
            <month>12</month>
            <year>2012</year>
         </date>
         <date date-type="accepted">
            <day>25</day>
            <month>3</month>
            <year>2013</year>
         </date>
      </history>
      <permissions>
         <copyright-year>2013</copyright-year>
         <copyright-holder>Meng et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
      <abstract>
         <sec>
            <title>Background</title>
            <p>To analyze the diagnostic value of color Doppler imaging (CDI) of blood flow in the retrobulbar vessels of eyes with primary open-angle glaucoma (POAG).</p>
         </sec>
         <sec>
            <title>Methods</title>
            <p>Pertinent publications were retrieved from the Cochrane Central Register of Controlled Trials, PubMed and the ISI Web of Knowledge up to October 2012. Changes in peak systolic velocity (PSV), end diastolic velocity (EDV) and resistive index (RI) of the ophthalmic artery (OA), central retinal artery (CRA) and short posterior ciliary artery (SPCA) of POAG eyes and normal controls were evaluated by CDI. Subgroup analyses were conducted according to whether patients received IOP-lowering drugs treatment and were defined as treated and untreated.</p>
         </sec>
         <sec>
            <title>Results</title>
            <p>PSV and EDV were statistically significantly reduced in the OA of POAG eyes (<italic>P = </italic>0.0002; <italic>P&lt;</italic>0.00001; respectively), with significant heterogeneity (<italic>P<sub>heterogeneity</sub>&lt;</italic>0.00001, <italic>I<sup>2</sup></italic> = 94%; <italic>P<sub>heterogeneity</sub>&lt;</italic>0.00001, <italic>I<sup>2</sup></italic> = 85%; respectively). Similar results were demonstrated for the CRA (<italic>P&lt;</italic>0.00001; respectively) and SPCA (<italic>P</italic> = 0.005; <italic>P&lt;</italic>0.00001; respectively), with significant heterogeneities for both the CRA (<italic>P<sub>heterogeneity</sub>&lt;</italic>0.00001, <italic>I<sup>2</sup></italic> = 81%; <italic>P<sub>heterogeneity</sub>&lt;</italic>0.00001, <italic>I<sup>2</sup></italic> = 98%; respectively) and the SPCA (<italic>P<sub>heterogeneity</sub>&lt;</italic>0.00001, <italic>I<sup>2</sup></italic> = 96%; <italic>P<sub>heterogeneity</sub>&lt;</italic>0.00001, <italic>I<sup>2</sup></italic> = 93%; respectively). Significant increases in RI were found in all retrobulbar vessels (<italic>P&lt;</italic>0.00001; respectively), with significant heterogeneities (<italic>P<sub>heterogeneity</sub>&lt;</italic>0.00001, <italic>I<sup>2</sup></italic> = 95%; <italic>P<sub>heterogeneity</sub>&lt;</italic>0.00001, <italic>I<sup>2</sup></italic> = 94%; <italic>P<sub>heterogeneity</sub>&lt;</italic>0.00001, <italic>I<sup>2</sup></italic> = 97%; respectively).</p>
         </sec>
         <sec>
            <title>Conclusions</title>
            <p>This meta-analysis suggests that CDI is a potential diagnostic tool for POAG.</p>
         </sec>
      </abstract>
      <funding-group>
         <funding-statement>This study was supported partly by Shandong Science and Technology Developing Project (2012GSF12121), Shandong Provincial Natural Science Foundation (Y2008C78) and Independent innovation foundation of Shandong University (IIFSDU 2012ZD025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
      </funding-group>
<counts>
<page-count count="12"/>
</counts>
</article-meta>
</front>
<body>
   <sec id="s1">
      <title>Introduction</title>
      <p>Primary open-angle glaucoma (POAG) is multifactorial in origin and characterized by optic nerve head excavation, visual field defects and psychophysical changes <xref ref-type="bibr" rid="pone.0062723-VanBuskirk1">[1]</xref>. One hypothesis for the pathogenesis of POAG is that a mechanical mechanism that elevated IOP blocks optic neuronal axoplasmic flow in the madreporite, ultimately leading to apoptosis of the ganglion cell <xref ref-type="bibr" rid="pone.0062723-Hayreh1">[2]</xref>. However, despite therapeutic IOP reduction, some patients still show signs of disease progression, which indicates that other factors might be involved in the glaucomatous damage. Recently, a hypothesis concerning the vasogenic mechanism of POAG was suggested that considers vascular dysregulation <xref ref-type="bibr" rid="pone.0062723-Resch1">[3]</xref>–<xref ref-type="bibr" rid="pone.0062723-Costa1">[5]</xref>. Inability of the perfusion system to adapt to tissue blood flow requirements or changes in perfusion pressure may lead to chronically low or unstable ocular perfusion <xref ref-type="bibr" rid="pone.0062723-Leske1">[6]</xref>, which in turn may cause ischemia, oxidative stress or both, possibly leading to glaucomatous damage to the optic nerve head. It seems that vascular factors are important in the development and progression of POAG.</p>
      <p>Various techniques have been used to evaluate ocular blood flow in patients with POAG, such as scanning ophthalmoscopy <xref ref-type="bibr" rid="pone.0062723-Wolf1">[7]</xref>, scanning laser Doppler flowmetry <xref ref-type="bibr" rid="pone.0062723-Chung1">[8]</xref>, <xref ref-type="bibr" rid="pone.0062723-Michelson1">[9]</xref> and pulsatile ocular blood flow <xref ref-type="bibr" rid="pone.0062723-Trew1">[10]</xref>, <xref ref-type="bibr" rid="pone.0062723-Langham1">[11]</xref>. Compared with these techniques, color Doppler imaging (CDI) has particular advantages in that it is noninvasive, is not affected by poor ocular media, requires no contrast or radiation, and has been used in ophthalmology for 20 years <xref ref-type="bibr" rid="pone.0062723-Lieb1">[12]</xref>, <xref ref-type="bibr" rid="pone.0062723-Kaiser1">[13]</xref>. This ultrasound technique combines simultaneous B-mode ultrasound imaging with colors representing movement based on Doppler frequency shifts. It allows the assessment of blood flow velocities including peak systolic velocity (PSV) and end diastolic velocity (EDV) in the ophthalmic artery (OA), central retinal artery (CRA) and short posterior ciliary artery (SPCA). In addition, resistive index (RI), a measure of peripheral vascular resistance, can be calculated for each retrobulbar vessel.</p>
      <p>Numerous studies have reported reduced PSV and EDV and increased RI in the OA, CRA and SPCA in eyes of POAG <xref ref-type="bibr" rid="pone.0062723-Garhofer1">[14]</xref>–<xref ref-type="bibr" rid="pone.0062723-Harris1">[16]</xref>. Some studies have found reduced blood flow velocities and increased RI in only one <xref ref-type="bibr" rid="pone.0062723-Erickson1">[17]</xref>–<xref ref-type="bibr" rid="pone.0062723-Butt1">[19]</xref> or two <xref ref-type="bibr" rid="pone.0062723-Butt2">[20]</xref>, <xref ref-type="bibr" rid="pone.0062723-Rankin1">[21]</xref> retrobulbar vessels. To the authors’ knowledge, no systematic review of the evidence for the diagnostic potential of CDI in POAG has been published. To obtain a better perspective of the above issues, we performed a meta-analysis of the literature to quantify the value of CDI in measuring the PSV, EDV and RI of the OA, CRA and SPCA in eyes with POAG compared with normal control subjects and to assess the diagnostic value of CDI in POAG.</p>
   </sec>
   <sec id="s2" sec-type="materials|methods">
      <title>Materials and Methods</title>
      <sec id="s2a">
         <title>Search and Selection</title>
         <p>Two researchers independently searched the literature in three databases – the Cochrane Central Register of Controlled Trials, PubMed and the ISI Web of Knowledge – up to October 2012. The search terms were ‘color Doppler imaging or colour Doppler imaging or Doppler ultrasound or CDI’, ‘ocular blood flow or retrobulbar blood flow’ and ‘primary open-angle glaucoma or POAG’ in various combinations, with the language limited to English. The reference lists of case reports, studies and review articles were also reviewed for any additional citations. Publications that involved the use of CDI measurements made in a supine or sitting position in the diagnosis of POAG were included.</p>
      </sec>
      <sec id="s2b">
         <title>Inclusion Criteria</title>
         <p>The definitions of POAG used in the included studies are shown in <xref ref-type="supplementary-material" rid="pone.0062723.s002">Table S2</xref>. Normal control subjects had IOP≤21 mm Hg, normal optic disc appearance and no visual field defect.</p>
         <p>All relevant articles were extracted in print and the final selection was based on discussion among the researchers. Studies were included if they: (i) were randomized clinical controlled trials or observational studies; and (ii) compared blood flow velocities including PSV, EDV and RI in the OA, CRA and SPCA in POAG and normal eyes. When multiple publications from the same study population were available, we checked for duplicate analysis and only the most recent publication was included. For more detailed information, see the PRISMA checklist (<xref ref-type="supplementary-material" rid="pone.0062723.s001">Table S1</xref>).</p>
      </sec>
      <sec id="s2c">
         <title>Data Extraction</title>
         <p>The following information was extracted by the investigators independently from the published reports, using a standardized protocol and reporting form: first author’s last name, year of publication, country of origin, number of enrolled eyes, mean age of subjects, definition of POAG, type of treatment, and mean change with standard deviations (SD) of measurement indicators.</p>
      </sec>
      <sec id="s2d">
         <title>Outcome Measures</title>
         <p>All studies had PSV and EDV measured by CDI in the OA, CRA and SPCA as major outcomes. PSV (cm/s) was defined as the highest blood flow velocity achieved during systole and was calculated from the frequency of the peak in the Doppler-shifted waveform. EDV (cm/s) was defined as the lowest velocity occurring during diastole and was calculated from the frequency of the trough in the Doppler-shifted waveform. RI was calculated according to the method of Pourcelot <xref ref-type="bibr" rid="pone.0062723-Planiol1">[22]</xref> as RI = (PSV - EDV)/PSV.</p>
      </sec>
      <sec id="s2e">
         <title>Statistical Analysis</title>
         <p>RevMan software (Review Manager, Version 5.1; The Cochrane Collaboration, 2011) was used for this meta-analysis. For every included study, we calculated the mean difference (MD) for the continuous outcomes (PSV, EDV or RI) along with 95% confidence intervals (95%CIs). The between-study heterogeneity (i.e. the variation in findings not compatible with chance alone) was tested using chi-square based Cochran’s statistics and the inconsistency index (<italic>I<sup>2</sup></italic>) <xref ref-type="bibr" rid="pone.0062723-Higgins1">[23]</xref>, which indicates the proportion of the variability across studies that is due to heterogeneity rather than sample error. Statistically significant heterogeneity was considered to be present when <italic>P<sub>heterogeneity</sub>&lt;</italic>0.05 and <italic>I<sup>2</sup></italic> &gt;50%. In the presence of substantial heterogeneity (<italic>I<sup>2</sup></italic> &gt;50%), a random effect model was adopted as the pooling method; otherwise, a fixed effect model was used. Beggar’s and Egger’s tests were used to determined publication bias <xref ref-type="bibr" rid="pone.0062723-Egger1">[24]</xref>, <xref ref-type="bibr" rid="pone.0062723-Begg1">[25]</xref>.</p>
         <p>Topical antiglaucoma medications may influence ocular blood flow by increasing flow velocities and reducing RI <xref ref-type="bibr" rid="pone.0062723-Baxter1">[26]</xref>, <xref ref-type="bibr" rid="pone.0062723-Steigerwalt1">[27]</xref>. Subgroup analyses were conducted according to whether POAG eyes received IOP-lowering drugs and were defined as treated and untreated subgroups. The treated subgroup included eyes that received IOP-lowering drugs and had well controlled IOP (data on duration of medication use were not available); the untreated subgroup included eyes with IOP&gt;21 mm Hg that was newly diagnosed and untreated. All data were displayed as forest plots.</p>
      </sec>
   </sec>
   <sec id="s3">
      <title>Results</title>
      <sec id="s3a">
         <title>Study Characteristics</title>
         <p><xref ref-type="fig" rid="pone-0062723-g001">Figure 1</xref> summarizes the selection of eligible studies. Twenty-three prospective observational studies of 1286 eyes with POAG and 1052 controls were included in the meta-analysis. Eighteen of the studies concerned POAG eyes that received IOP-lowering drugs and had well controlled IOP <xref ref-type="bibr" rid="pone.0062723-Garhofer1">[14]</xref>, <xref ref-type="bibr" rid="pone.0062723-Rankin1">[21]</xref>, <xref ref-type="bibr" rid="pone.0062723-AbegaoPinto2">[28]</xref>–<xref ref-type="bibr" rid="pone.0062723-Liu2">[43]</xref>; five studies concerned newly diagnosed and untreated POAG <xref ref-type="bibr" rid="pone.0062723-Butt1">[19]</xref>, <xref ref-type="bibr" rid="pone.0062723-JanulevicieneI1">[44]</xref>–<xref ref-type="bibr" rid="pone.0062723-Simsek1">[47]</xref>. CDI was conducted in a sitting position in three studies <xref ref-type="bibr" rid="pone.0062723-Galambos1">[31]</xref>, <xref ref-type="bibr" rid="pone.0062723-Galassi1">[40]</xref>, <xref ref-type="bibr" rid="pone.0062723-JanulevicieneI1">[44]</xref> and in a supine position in the remaining 20 studies <xref ref-type="bibr" rid="pone.0062723-Garhofer1">[14]</xref>, <xref ref-type="bibr" rid="pone.0062723-Butt1">[19]</xref>, <xref ref-type="bibr" rid="pone.0062723-Rankin1">[21]</xref>, <xref ref-type="bibr" rid="pone.0062723-AbegaoPinto2">[28]</xref>–<xref ref-type="bibr" rid="pone.0062723-Detorakis1">[30]</xref>, <xref ref-type="bibr" rid="pone.0062723-Gherghel1">[32]</xref>–<xref ref-type="bibr" rid="pone.0062723-Yuksel1">[39]</xref>, <xref ref-type="bibr" rid="pone.0062723-MartinezA1">[41]</xref>–<xref ref-type="bibr" rid="pone.0062723-Liu2">[43]</xref>, <xref ref-type="bibr" rid="pone.0062723-Akarsu1">[45]</xref>–<xref ref-type="bibr" rid="pone.0062723-Simsek1">[47]</xref>. All of the included studies were of reasonably good quality.</p>
         <fig id="pone-0062723-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0062723.g001</object-id><label>Figure 1</label>
            <caption>
               <title>Flowchart of the literature selection process.</title>
            </caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0062723.g001" position="float" xlink:type="simple"/></fig>
         <p>The detailed characteristics of the participants in the 23 studies are given in <xref ref-type="supplementary-material" rid="pone.0062723.s002">Table S2</xref>. The subjects’ ages ranged from 38.6 to 83.9 years old; the gender distributions of POAG patients and normal control subjects were similar. Clinical heterogeneity was observed in several areas, including the specific characteristics of glaucoma and different treatment protocols. However, these factors were not reported consistently in the publications and hence were not analyzed here.</p>
      </sec>
      <sec id="s3b">
         <title>Summary Results for PSV, EDV and RI</title>
         <sec id="s3b1">
            <title>PSV</title>
            <p>Differences in the mean change in PSV for each retrobulbar vessel, along with SDs and 95%CIs, are outlined in the forest plot displayed in <xref ref-type="fig" rid="pone-0062723-g002">Figure 2</xref>, <xref ref-type="fig" rid="pone-0062723-g003">3</xref> and <xref ref-type="fig" rid="pone-0062723-g004">4</xref>. The dots represent MDs; the whiskers extending from the dots show the associated 95%CIs. Values on the left side of the vertical line at 0 represent greater changes in PSV in normal controls; values on the right side of the vertical line represent greater changes in eyes with POAG. 95%CIs that do not intersect with the vertical line at 0 indicate the results that were statistically significant at the 0.05 level.</p>
            <fig id="pone-0062723-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0062723.g002</object-id><label>Figure 2</label>
               <caption>
                  <title>Results of PSV in OA.</title>
                  <p>The forest plot showed the studies’ MDs in PSV in cm/s along with their associated 95%CIs, comparing POAG eyes with normal controls. PSV was significantly decreased in OA in POAG eyes. Subgroup analysis showed that the heterogeneity in OA was due to both the untreated and IOP-lowering drugs treatment subgroup. Negative values favored POAG eyes over normal controls; positive values favored normal controls over POAG eyes.</p>
               </caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0062723.g002" position="float" xlink:type="simple"/></fig>
            <fig id="pone-0062723-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0062723.g003</object-id><label>Figure 3</label>
               <caption>
                  <title>Results of PSV in CRA.</title>
                  <p>PSV was significantly decreased in CRA. Subgroup analysis showed that the heterogeneity in CRA was due to both the untreated and IOP-lowering drugs treatment subgroup.</p>
               </caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0062723.g003" position="float" xlink:type="simple"/></fig>
            <fig id="pone-0062723-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0062723.g004</object-id><label>Figure 4</label>
               <caption>
                  <title>Results of PSV in SPCA.</title>
                  <p>PSV was significantly decreased in SPCA. Subgroup analysis showed that the heterogeneity in SPCA was due to both the untreated and IOP-lowering drugs treatment subgroup.</p>
               </caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0062723.g004" position="float" xlink:type="simple"/></fig>
            <p>Significant reductions in PSV in the OA and CRA of POAG eyes were found in 20 studies, with a total summary MDs of –2.87 cm/s (95%CI: –4.36 to –1.38, <italic>P = </italic>0.0002; <xref ref-type="fig" rid="pone-0062723-g002">Figure 2</xref>) and –1.60 cm/s (95%CI: –1.88 to –1.32, <italic>P&lt;</italic>0.00001; <xref ref-type="fig" rid="pone-0062723-g003">Figure 3</xref>) and significant heterogeneities (<italic>P<sub>heterogeneity</sub>&lt;</italic>0.00001, <italic>I<sup>2</sup></italic> = 94%; <italic>P<sub>heterogeneity</sub>&lt;</italic>0.00001, <italic>I<sup>2</sup></italic> = 81%; respectively). Significant reductions in PSV in the SPCA of POAG eyes were demonstrated in 18 studies, with a MD of –0.87 cm/s (95%CI: –1.49 to –0.26, <italic>P = </italic>0.005; <xref ref-type="fig" rid="pone-0062723-g004">Figure 4</xref>) and significant heterogeneity (P<sub>heterogeneity</sub><italic>&lt;</italic>0.00001, I<sup>2</sup> = 96%). Subgroup analysis of PSV in the OA, CRA and SPCA found significant heterogeneities in both the treated and untreated subgroups (<italic>P<sub>heterogeneity</sub>&lt;</italic>0.00001, <italic>I<sup>2</sup></italic> = 95% and <italic>P<sub>heterogeneity</sub>&lt;</italic>0.0001, <italic>I<sup>2</sup></italic> = 83%, <xref ref-type="fig" rid="pone-0062723-g002">Figure 2</xref>; <italic>P<sub>heterogeneity</sub>&lt;</italic>0.00001, <italic>I<sup>2</sup></italic> = 84% and <italic>P<sub>heterogeneity</sub></italic> = 0.02, <italic>I<sup>2</sup></italic> = 66%, <xref ref-type="fig" rid="pone-0062723-g003">Figure 3</xref>; <italic>P<sub>heterogeneity</sub>&lt;</italic>0.00001, <italic>I<sup>2</sup></italic> = 96% and <italic>P<sub>heterogeneity</sub></italic> = 0.007, <italic>I<sup>2</sup></italic> = 75%, <xref ref-type="fig" rid="pone-0062723-g004">Figure 4</xref>).</p>
         </sec>
         <sec id="s3b2">
            <title>EDV</title>
            <p><xref ref-type="fig" rid="pone-0062723-g005">Figure 5</xref>, <xref ref-type="fig" rid="pone-0062723-g006">6</xref> and <xref ref-type="fig" rid="pone-0062723-g007">7</xref> show the forest plot for EDV in the OA, CRA and SPCA comparing POAG eyes with controls. Similar to the PSV outcomes, POAG eyes had significantly lower EDV in the OA with a MD of –1.55 cm/s (95%CI: –1.89 to –1.20, <italic>P&lt;</italic>0.00001; <xref ref-type="fig" rid="pone-0062723-g005">Figure 5</xref>), in the CRA with a MD of –0.90 cm/s (95%CI: –1.12 to –0.68, <italic>P&lt;</italic>0.00001; <xref ref-type="fig" rid="pone-0062723-g006">Figure 6</xref>) and in the SPCA with a MD of –0.53 cm/s (95%CI: –0.71 to –0.36, <italic>P&lt;</italic>0.00001; <xref ref-type="fig" rid="pone-0062723-g007">Figure 7</xref>). The heterogeneity was significant for the EDV in each retrobulbar vessel (<italic>P<sub>heterogeneity</sub>&lt;</italic>0.00001, <italic>I<sup>2</sup></italic> = 85%; <italic>P<sub>heterogeneity</sub>&lt;</italic>0.00001, <italic>I<sup>2</sup></italic> = 98%; <italic>P<sub>heterogeneity</sub>&lt;</italic>0.00001, <italic>I<sup>2</sup></italic> = 93%; respectively). Subgroup analysis of EDV in the OA, CRA and SPCA found significant heterogeneities in both the treated and untreated subgroups (<italic>P<sub>heterogeneity</sub>&lt;</italic>0.00001, <italic>I<sup>2</sup></italic> = 87% and <italic>P<sub>heterogeneit</sub></italic><sub>y</sub> = 0.03, <italic>I<sup>2</sup></italic> = 6 1%, <xref ref-type="fig" rid="pone-0062723-g005">Figure 5</xref>; <italic>P<sub>heterogeneity</sub>&lt;</italic>0.00001, <italic>I<sup>2</sup></italic> = 99% and <italic>P<sub>heterogeneity</sub></italic> = 0.007, <italic>I<sup>2</sup></italic> = 72%, <xref ref-type="fig" rid="pone-0062723-g006">Figure 6</xref>; <italic>P<sub>heterogeneity</sub>&lt;</italic>0.00001, <italic>I<sup>2</sup></italic> = 94% and <italic>P<sub>heterogeneity</sub>&lt;</italic>0.00001, <italic>I<sup>2</sup></italic> = 89%, <xref ref-type="fig" rid="pone-0062723-g007">Figure 7</xref>).</p>
            <fig id="pone-0062723-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0062723.g005</object-id><label>Figure 5</label>
               <caption>
                  <title>Results of EDV in OA.</title>
                  <p>The forest plot showed the studies’ MDs in EDV in cm/s along with their associated 95%CIs, comparing POAG eyes with normal controls. EDV was significantly decreased in OA in POAG eyes. Subgroup analysis showed the heterogeneity in OA was due to both the untreated and IOP-lowering drugs treatment subgroup. Negative values favored POAG eyes over normal controls; positive values favored normal controls over POAG eyes.</p>
               </caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0062723.g005" position="float" xlink:type="simple"/></fig>
            <fig id="pone-0062723-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0062723.g006</object-id><label>Figure 6</label>
               <caption>
                  <title>Results of EDV in CRA.</title>
                  <p>EDV was significantly decreased in CRA in POAG eyes. Subgroup analysis showed the heterogeneity in CRA was due to both the untreated and IOP-lowering drugs treatment subgroup.</p>
               </caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0062723.g006" position="float" xlink:type="simple"/></fig>
            <fig id="pone-0062723-g007" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0062723.g007</object-id><label>Figure 7</label>
               <caption>
                  <title>Results of EDV in SPCA.</title>
                  <p>EDV was significantly decreased in SPCA in POAG eyes. Subgroup analysis showed the heterogeneity in SPCA was due to both the untreated and IOP-lowering drugs treatment subgroup.</p>
               </caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0062723.g007" position="float" xlink:type="simple"/></fig>
         </sec>
         <sec id="s3b3">
            <title>RI</title>
            <p>The results for RI in the OA, CRA and SPCA are shown in <xref ref-type="fig" rid="pone-0062723-g008">Figure 8</xref>, <xref ref-type="fig" rid="pone-0062723-g009">9</xref> and <xref ref-type="fig" rid="pone-0062723-g010">10</xref>. Significant increases were observed; the MD was 0.04 in the OA (95%CI: 0.03 to 0.05, <italic>P&lt;</italic>0.00001; <xref ref-type="fig" rid="pone-0062723-g008">Figure 8</xref>), 0.06 in the CRA (95%CI: 0.04 to 0.07, <italic>P&lt;</italic>0.00001; <xref ref-type="fig" rid="pone-0062723-g009">Figure 9</xref>) and 0.04 in the SPCA (95%CI: 0.03 to 0.06, <italic>P&lt;</italic>0.00001; <xref ref-type="fig" rid="pone-0062723-g010">Figure 10</xref>), with significant heterogeneities (<italic>P<sub>heterogeneity</sub>&lt;</italic>0.00001, <italic>I<sup>2</sup></italic> = 95%; <italic>P<sub>heterogeneity</sub>&lt;</italic>0.00001, <italic>I<sup>2</sup></italic> = 94%; <italic>P<sub>heterogeneity</sub>&lt;</italic>0.00001, <italic>I<sup>2</sup></italic> = 97%; respectively). Subgroup analysis demonstrated that the heterogeneities in OA and CRA were due to IOP-lowering drug treatment (<italic>P<sub>heterogeneity</sub>&lt;</italic>0.00001, <italic>I<sup>2</sup></italic> = 96%; <italic>P<sub>heterogeneity</sub>&lt;</italic>0.00001, I<sup>2</sup> = 95%; <xref ref-type="fig" rid="pone-0062723-g008">Figure 8</xref> and <xref ref-type="fig" rid="pone-0062723-g009">9</xref>). The heterogeneity in the SPCA was significant in both the treated and untreated subgroups (<italic>P<sub>heterogeneity</sub>&lt;</italic>0.00001, <italic>I<sup>2</sup></italic> = 98%; <italic>P<sub>heterogeneity = </sub></italic>0.0005, <italic>I<sup>2</sup></italic> = 83%; <xref ref-type="fig" rid="pone-0062723-g010">Figure 10</xref>).</p>
            <fig id="pone-0062723-g008" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0062723.g008</object-id><label>Figure 8</label>
               <caption>
                  <title>Results of RI in OA.</title>
                  <p>The forest plot showed the studies’ MDs in RI along with their associated 95%CIs, comparing POAG eyes with normal controls. RI was significantly increased in OA in POAG eyes. Subgroup analysis demonstrated the heterogeneity in OA was due to the IOP-lowering drugs treatment. Negative values favored POAG eyes over normal controls; positive values favored normal controls over POAG eyes.</p>
               </caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0062723.g008" position="float" xlink:type="simple"/></fig>
            <fig id="pone-0062723-g009" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0062723.g009</object-id><label>Figure 9</label>
               <caption>
                  <title>Results of RI in CRA.</title>
                  <p>RI was significantly increased in CRA in POAG eyes. Subgroup analysis demonstrated the heterogeneity in CRA was due to the IOP-lowering drugs treatment.</p>
               </caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0062723.g009" position="float" xlink:type="simple"/></fig>
            <fig id="pone-0062723-g010" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0062723.g010</object-id><label>Figure 10</label>
               <caption>
                  <title>Results of RI in SPCA.</title>
                  <p>RI was significantly increased in SPCA in POAG eyes.</p>
               </caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0062723.g010" position="float" xlink:type="simple"/></fig>
         </sec>
      </sec>
   </sec>
   <sec id="s4">
      <title>Discussion</title>
      <p>POAG has long been recognized as the major cause for legal blindness worldwide <xref ref-type="bibr" rid="pone.0062723-Quigley1">[48]</xref>. For decades, extensive studies have been conducted in attempts to identify the precise pathogenesis of POAG and potential diagnostic methods for its detection.</p>
      <p>This meta-analysis was conducted to evaluate the differences in blood flow parameters in the retrobulbar vessels using CDI. CDI measures blood flow velocity but not actual blood flow, because it is impossible to determine accurately the diameter of orbital vessels in vivo with this technique. Despite this limitation, blood flow velocity is probably a good indicator of blood flow within a given vessel <xref ref-type="bibr" rid="pone.0062723-Hansen1">[49]</xref>,<xref ref-type="bibr" rid="pone.0062723-Taylor1">[50]</xref>. We found that, in eyes with POAG, PSV and EDV in the OA, CRA and SPCA were significantly decreased, whereas the RI in these retrobulbar vessels was significantly increased. The general consensus is that the main blood supply of the anterior optic nerve head is derived from the SPCA, with small contributions from the pial vessels and CRA; the retina derives its blood supply mainly from the CRA. Both the CRA and the SPCA are branches of the OA, which is the main arterial supply to the eyes; therefore, the hemodynamic parameters of the OA, CRA and SPCA reflect local blood supply conditions in the optic disc and retina. PSV reflects the strength of vessel perfusion, whereas EDV reflects the blood perfusion of distal organs and is a sensitive indicator of increased downstream impedance. RI is considered to reflect vascular resistance peripheral to the location where the measurements is made, but is not equivalent to vascular resistance because it depends on both vascular resistance and vascular compliance; only at high vascular compliance is RI an adequate measure of vascular resistance. However, the association of lower EDV with higher RI could be explained by increased vascular resistance <xref ref-type="bibr" rid="pone.0062723-Platt1">[51]</xref>,<xref ref-type="bibr" rid="pone.0062723-Rifkin1">[52]</xref> and changes in resistance affect diastolic blood flow velocity more than systolic velocity <xref ref-type="bibr" rid="pone.0062723-Taylor1">[50]</xref>, which further aggravates the ischemia of organs. Therefore, decreased blood velocity and increased RI can result in ischemia of the optic disc and, ultimately, glaucomatous damages to the optic nerve head <xref ref-type="bibr" rid="pone.0062723-Leske1">[6]</xref>.</p>
      <p>In this meta-analysis, we found that PSV and EDV were decreased in each retrobulbar vessel in both untreated and IOP-controlled POAG eyes. Considering that the retinal nerve fiber layer in eyes with POAG has been reported to be thinner than that in normal eyes <xref ref-type="bibr" rid="pone.0062723-Brusini1">[53]</xref>,<xref ref-type="bibr" rid="pone.0062723-Sihota1">[54]</xref>, we believe that retrobulbar blood flow reductions affect not only the optic disc, but also the retina. Apoptosis of ganglion cells is probably due to blood flow reduction in the CRA, which is the main artery supplying the inner retina.</p>
      <p>The primary limitation of this meta-analysis was that observational studies rather than randomized clinical controlled trials were included. Furthermore, only studies published in English were involved.</p>
      <p>Publication bias could have distorted our findings, though no significant publication bias was found. Funnel plots were symmetric (Data not shown) and consistent results were obtained from the Beggar’s and Egger’s tests. Nevertheless, publication bias remains a possibility because studies that report statistically significant results are more likely to be published than those that report non-significant results. Moreover, we did not include unpublished data from conference abstracts, dissertations or pharmaceutical companies.</p>
      <p>There was considerable heterogeneity between the studies assessed here, which may be attributable to patient characteristics, types of antiglaucoma medications used, sample size, diagnostic bias, operator experience or CDI devices used. As shown in <xref ref-type="supplementary-material" rid="pone.0062723.s002">Table S2</xref>, antiglaucoma medications and sample size varied and could have been a source of heterogeneity. The diagnostic criteria for POAG differed among the included studies, which might have led to diagnostic bias; definitions were based on a combination of glaucomatous visual field loss and optic disc abnormalities in most studies, with various criteria and cutoff points (<xref ref-type="supplementary-material" rid="pone.0062723.s002">Table S2</xref>). In addition, the interpretation of CDI measurements may be operator dependent and it is possible that this is reflected in the heterogeneity. Means of sensitivities, specificities and positive predictive values for different CDI devices are variable and may also resulted in heterogeneity in this meta-analysis. We were unable to conduct regression analysis of the results to explore study-level factors that might have explained some of the heterogeneity.</p>
      <p>In summary, our data suggest that blood flow velocities were reduced and RI was increased in all retrobulbar vessels in POAG eyes. Changes of ocular blood flow are important in the development of POAG and CDI is therefore a potential diagnostic tool for this condition.</p>
   </sec>
   <sec id="s5">
      <title>Supporting Information</title>
<supplementary-material id="pone.0062723.s001" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pone.0062723.s001" position="float" xlink:type="simple">
<label>Table S1</label>
<caption><p><bold>PRISMA checklist.</bold></p>
      <p>(DOC)</p>
</caption></supplementary-material>
<supplementary-material id="pone.0062723.s002" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pone.0062723.s002" position="float" xlink:type="simple">
<label>Table S2</label>
<caption><p><bold>characteristics of included studies.</bold></p>
      <p>(DOC)</p>
</caption></supplementary-material>
   </sec>
</body>
<back>
   <ack>
      <p>The authors thank the authors whose studies were involved in this meta-analysis and provided useful data to us.</p>
      <sec>
         <title>Contributions</title>
         <p>Collection and management of the data: NM PZ HH JM YZ HL YQ. Conceived and designed the experiments: NM YQ. Analyzed the data: NM YQ. Contributed reagents/materials/analysis tools: PZ HH. Wrote the paper: NM YQ.</p>
      </sec>
   </ack>
   <ref-list>
      <title>References</title>
      <ref id="pone.0062723-VanBuskirk1"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Van Buskirk</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Cioffi</surname><given-names>GA</given-names></name> (<year>1992</year>) <article-title>Glaucomatous optic neuropathy</article-title>. <source>Am J Ophthalmol</source> <volume>113</volume>: <fpage>447</fpage>–<lpage>452</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Hayreh1"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hayreh</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Revie</surname><given-names>IH</given-names></name>, <name name-style="western"><surname>Edwards</surname><given-names>J</given-names></name> (<year>1970</year>) <article-title>Vasogenic origin of visual field defects and optic nerve changes in glaucoma</article-title>. <source>Br J Ophthalmol</source> <volume>54</volume>: <fpage>461</fpage>–<lpage>472</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Resch1"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Resch</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Garhofer</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Fuchsjager-Mayrl</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Hommer</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Schmetterer</surname><given-names>L</given-names></name> (<year>2009</year>) <article-title>Endothelial dysfunction in glaucoma</article-title>. <source>Acta Ophthalmol</source> <volume>87</volume>: <fpage>4</fpage>–<lpage>12</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Flammer1"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Flammer</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Orgul</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Costa</surname><given-names>VP</given-names></name>, <name name-style="western"><surname>Orzalesi</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Krieglstein</surname><given-names>GK</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>The impact of ocular blood flow in glaucoma</article-title>. <source>Prog Retin Eye Res</source> <volume>21</volume>: <fpage>359</fpage>–<lpage>393</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Costa1"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Costa</surname><given-names>VP</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Stefansson</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Flammer</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Krieglstein</surname><given-names>GK</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>The effects of antiglaucoma and systemic medications on ocular blood flow</article-title>. <source>Prog Retin Eye Res</source> <volume>22</volume>: <fpage>769</fpage>–<lpage>805</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Leske1"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leske</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Heijl</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hyman</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Bengtsson</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Dong</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Predictors of long-term progression in the early manifest glaucoma trial</article-title>. <source>Ophthalmology</source> <volume>114</volume>: <fpage>1965</fpage>–<lpage>1972</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Wolf1"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wolf</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Arend</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Sponsel</surname><given-names>WE</given-names></name>, <name name-style="western"><surname>Schulte</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Cantor</surname><given-names>LB</given-names></name>, <etal>et al</etal>. (<year>1993</year>) <article-title>Retinal hemodynamics using scanning laser ophthalmoscopy and hemorheology in chronic open-angle glaucoma</article-title>. <source>Ophthalmology</source> <volume>100</volume>: <fpage>1561</fpage>–<lpage>1566</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Chung1"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chung</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kagemann</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>B</given-names></name> (<year>1999</year>) <article-title>Peripapillary retinal blood flow in normal tension glaucoma</article-title>. <source>Br J Ophthalmol</source> <volume>83</volume>: <fpage>466</fpage>–<lpage>469</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Michelson1"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Michelson</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Langhans</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Groh</surname><given-names>MJ</given-names></name> (<year>1996</year>) <article-title>Perfusion of the juxtapapillary retina and the neuroretinal rim area in primary open angle glaucoma</article-title>. <source>J Glaucoma</source> <volume>5</volume>: <fpage>91</fpage>–<lpage>98</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Trew1"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Trew</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>SE</given-names></name> (<year>1991</year>) <article-title>Postural studies in pulsatile ocular blood flow: II. Chronic open angle glaucoma</article-title>. <source>Br J Ophthalmol</source> <volume>75</volume>: <fpage>71</fpage>–<lpage>75</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Langham1"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Langham</surname><given-names>ME</given-names></name> (<year>1994</year>) <article-title>Ocular blood flow and vision in healthy and glaucomatous eyes</article-title>. <source>Surv Ophthalmol</source> <volume>38</volume> Suppl: S161–168</mixed-citation></ref>
      <ref id="pone.0062723-Lieb1"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lieb</surname><given-names>WE</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Merton</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Shields</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Mitchell</surname><given-names>DG</given-names></name>, <etal>et al</etal>. (<year>1991</year>) <article-title>Color Doppler imaging of the eye and orbit. Technique and normal vascular anatomy</article-title>. <source>Arch Ophthalmol</source> <volume>109</volume>: <fpage>527</fpage>–<lpage>531</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Kaiser1"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kaiser</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Schotzau</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Flammer</surname><given-names>J</given-names></name> (<year>1996</year>) <article-title>Blood-flow velocities in the extraocular vessels in normal volunteers</article-title>. <source>Am J Ophthalmol</source> <volume>122</volume>: <fpage>364</fpage>–<lpage>370</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Garhofer1"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Garhofer</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Fuchsjager-Mayrl</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Vass</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Pemp</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Hommer</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Retrobulbar blood flow velocities in open angle glaucoma and their association with mean arterial blood pressure</article-title>. <source>Invest Ophthalmol Vis Sci</source> <volume>51</volume>: <fpage>6652</fpage>–<lpage>6657</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Cellini1"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cellini</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Possati</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Caramazza</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Caramazza</surname><given-names>R</given-names></name> (<year>1996</year>) <article-title>Colour Doppler analysis of the choroidal circulation in chronic open-angle glaucoma</article-title>. <source>Ophthalmologica</source> <volume>210</volume>: <fpage>200</fpage>–<lpage>202</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Harris1"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Harris</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sergott</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Spaeth</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Katz</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Shoemaker</surname><given-names>JA</given-names></name>, <etal>et al</etal>. (<year>1994</year>) <article-title>Color Doppler analysis of ocular vessel blood velocity in normal-tension glaucoma</article-title>. <source>Am J Ophthalmol</source> <volume>118</volume>: <fpage>642</fpage>–<lpage>649</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Erickson1"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Erickson</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Hendrix</surname><given-names>LE</given-names></name>, <name name-style="western"><surname>Massaro</surname><given-names>BM</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Lewandowski</surname><given-names>MF</given-names></name>, <etal>et al</etal>. (<year>1989</year>) <article-title>Color Doppler flow imaging of the normal and abnormal orbit</article-title>. <source>Radiology</source> <volume>173</volume>: <fpage>511</fpage>–<lpage>516</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-AbegaoPinto1"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Abegao Pinto</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Vandewalle</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Stalmans</surname><given-names>I</given-names></name> (<year>2012</year>) <article-title>Disturbed correlation between arterial resistance and pulsatility in glaucoma patients</article-title>. <source>Acta Ophthalmol</source> <volume>90</volume>: <fpage>214</fpage>–<lpage>220</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Butt1"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Butt</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>O'Brien</surname><given-names>C</given-names></name>, <name name-style="western"><surname>McKillop</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Aspinall</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Allan</surname><given-names>P</given-names></name> (<year>1997</year>) <article-title>Color Doppler imaging in untreated high- and normal-pressure open-angle glaucoma</article-title>. <source>Invest Ophthalmol Vis Sci</source> <volume>38</volume>: <fpage>690</fpage>–<lpage>696</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Butt2"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Butt</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>McKillop</surname><given-names>G</given-names></name>, <name name-style="western"><surname>O'Brien</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Allan</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Aspinall</surname><given-names>P</given-names></name> (<year>1995</year>) <article-title>Measurement of ocular blood flow velocity using colour Doppler imaging in low tension glaucoma</article-title>. <source>Eye (Lond) 9 (Pt</source> <volume>1)</volume>: <fpage>29</fpage>–<lpage>33</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Rankin1"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rankin</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Walman</surname><given-names>BE</given-names></name>, <name name-style="western"><surname>Buckley</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Drance</surname><given-names>SM</given-names></name> (<year>1995</year>) <article-title>Color Doppler imaging and spectral analysis of the optic nerve vasculature in glaucoma</article-title>. <source>Am J Ophthalmol</source> <volume>119</volume>: <fpage>685</fpage>–<lpage>693</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Planiol1"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Planiol</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Pourcelot</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Pottier</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Degiovanni</surname><given-names>E</given-names></name> (<year>1972</year>) <article-title>[Study of carotid circulation by means of ultrasonic methods and thermography]</article-title>. <source>Rev Neurol (Paris)</source> <volume>126</volume>: <fpage>127</fpage>–<lpage>141</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Higgins1"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Deeks</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name> (<year>2003</year>) <article-title>Measuring inconsistency in meta-analyses</article-title>. <source>Bmj</source> <volume>327</volume>: <fpage>557</fpage>–<lpage>560</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Egger1"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Davey Smith</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Schneider</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname><given-names>C</given-names></name> (<year>1997</year>) <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>Bmj</source> <volume>315</volume>: <fpage>629</fpage>–<lpage>634</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Begg1"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname><given-names>M</given-names></name> (<year>1994</year>) <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source> <volume>50</volume>: <fpage>1088</fpage>–<lpage>1101</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Baxter1"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Baxter</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Williamson</surname><given-names>TH</given-names></name>, <name name-style="western"><surname>McKillop</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Dutton</surname><given-names>GN</given-names></name> (<year>1992</year>) <article-title>Color Doppler ultrasound of orbital and optic nerve blood flow: effects of posture and timolol 0.5%</article-title>. <source>Invest Ophthalmol Vis Sci</source> <volume>33</volume>: <fpage>604</fpage>–<lpage>610</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Steigerwalt1"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Steigerwalt</surname><given-names>RD</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Belcaro</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Cesarone</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Laurora</surname><given-names>G</given-names></name>, <name name-style="western"><surname>De Sanctis</surname><given-names>MT</given-names></name>, <etal>et al</etal>. (<year>1993</year>) <article-title>Doppler ultrasonography of the central retinal artery in normals treated with topical timolol</article-title>. <source>Eye (Lond) 7 (Pt</source> <volume>3)</volume>: <fpage>403</fpage>–<lpage>406</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-AbegaoPinto2"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Abegao Pinto L, Vandewalle E, De Clerck E, Marques-Neves C, Stalmans I (2012) Lack of spontaneous venous pulsation: possible risk indicator in normal tension glaucoma? Acta Ophthalmol.</mixed-citation></ref>
      <ref id="pone.0062723-Birinci1"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Birinci</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Danaci</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Oge</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Erkan</surname><given-names>ND</given-names></name> (<year>2002</year>) <article-title>Ocular blood flow in healthy and primary open-angle glaucomatous eyes</article-title>. <source>Ophthalmologica</source> <volume>216</volume>: <fpage>434</fpage>–<lpage>437</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Detorakis1"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Detorakis</surname><given-names>ET</given-names></name>, <name name-style="western"><surname>Achtaropoulos</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Drakonaki</surname><given-names>EE</given-names></name>, <name name-style="western"><surname>Kozobolis</surname><given-names>VP</given-names></name> (<year>2007</year>) <article-title>Hemodynamic evaluation of the posterior ciliary circulation in exfoliation syndrome and exfoliation glaucoma</article-title>. <source>Graefes Arch Clin Exp Ophthalmol</source> <volume>245</volume>: <fpage>516</fpage>–<lpage>521</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Galambos1"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Galambos</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Vafiadis</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Vilchez</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Wagenfeld</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Matthiessen</surname><given-names>ET</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Compromised autoregulatory control of ocular hemodynamics in glaucoma patients after postural change</article-title>. <source>Ophthalmology</source> <volume>113</volume>: <fpage>1832</fpage>–<lpage>1836</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Gherghel1"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gherghel</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Orgul</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gugleta</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Gekkieva</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Flammer</surname><given-names>J</given-names></name> (<year>2000</year>) <article-title>Relationship between ocular perfusion pressure and retrobulbar blood flow in patients with glaucoma with progressive damage</article-title>. <source>Am J Ophthalmol</source> <volume>130</volume>: <fpage>597</fpage>–<lpage>605</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Gugleta1"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gugleta</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Orgul</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Flammer</surname><given-names>J</given-names></name> (<year>1999</year>) <article-title>Is corneal temperature correlated with blood-flow velocity in the ophthalmic artery?</article-title> <source>Curr Eye Res</source> <volume>19</volume>: <fpage>496</fpage>–<lpage>501</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Kaiser2"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kaiser</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Schoetzau</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Stumpfig</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Flammer</surname><given-names>J</given-names></name> (<year>1997</year>) <article-title>Blood-flow velocities of the extraocular vessels in patients with high-tension and normal-tension primary open-angle glaucoma</article-title>. <source>Am J Ophthalmol</source> <volume>123</volume>: <fpage>320</fpage>–<lpage>327</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Liu1"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Chiou</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Chiang</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Chou</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Chou</surname><given-names>YH</given-names></name>, <etal>et al</etal>. (<year>1999</year>) <article-title>Variations in ocular hemodynamics in patients with early and late glaucoma</article-title>. <source>Acta Ophthalmol Scand</source> <volume>77</volume>: <fpage>658</fpage>–<lpage>662</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Pemp1"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pemp</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Garhofer</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Lasta</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Schmidl</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Wolzt</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>The effects of moxaverine on ocular blood flow in patients with age-related macular degeneration or primary open angle glaucoma and in healthy control subjects</article-title>. <source>Acta Ophthalmol</source> <volume>90</volume>: <fpage>139</fpage>–<lpage>145</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Sekeroglu1"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sekeroglu</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Irkec</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mocan</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Ileri</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Dikmenoglu</surname><given-names>N</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>The association of ocular blood flow with haemorheological parameters in primary open-angle and exfoliative glaucoma</article-title>. <source>Acta Ophthalmol</source> <volume>89</volume>: <fpage>429</fpage>–<lpage>434</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Stalmans1"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stalmans</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fieuws</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zeyen</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Vanbellinghen</surname><given-names>V</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Color Doppler imaging and ocular pulse amplitude in glaucomatous and healthy eyes</article-title>. <source>Eur J Ophthalmol</source> <volume>19</volume>: <fpage>580</fpage>–<lpage>587</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Yuksel1"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yuksel</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Karabas</surname><given-names>VL</given-names></name>, <name name-style="western"><surname>Demirci</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Arslan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Altintas</surname><given-names>O</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Comparison of blood flow velocities of the extraocular vessels in patients with pseudoexfoliation or primary open-angle glaucoma</article-title>. <source>Ophthalmologica</source> <volume>215</volume>: <fpage>424</fpage>–<lpage>429</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Galassi1"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Galassi</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Giambene</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Menchini</surname><given-names>U</given-names></name> (<year>2008</year>) <article-title>Ocular perfusion pressure and retrobulbar haemodynamics in pseudoexfoliative glaucoma</article-title>. <source>Graefes Arch Clin Exp Ophthalmol</source> <volume>246</volume>: <fpage>411</fpage>–<lpage>416</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-MartinezA1"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Martinez A</surname><given-names>GF</given-names></name>, <name name-style="western"><surname>Capeans</surname><given-names>C</given-names></name> (<year>1999</year>) <article-title>Dorzolamide effect on ocular blood flow</article-title>. <volume>40</volume>: <fpage>1270</fpage>–<lpage>1275</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Hosking1"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hosking</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Chung</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Jonescu-Cuypers</surname><given-names>CP</given-names></name>, <name name-style="western"><surname>Kagemann</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Ocular haemodynamic responses to induced hypercapnia and hyperoxia in glaucoma</article-title>. <source>Br J Ophthalmol</source> <volume>88</volume>: <fpage>406</fpage>–<lpage>411</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Liu2"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Ge</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Cai</surname><given-names>X</given-names></name> (<year>1998</year>) <article-title>Hemodynamics of ophthalmic artery and central retinal artery and correlation with other factors in patients with primary open angle glaucoma</article-title>. <source>Yan Ke Xue Bao</source> <volume>14</volume>: <fpage>138</fpage>–<lpage>144</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-JanulevicieneI1"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Januleviciene I</surname><given-names>SI</given-names></name>, <name name-style="western"><surname>Siesky</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>A</given-names></name> (<year>2008</year>) <article-title>Diagnostic compatibility of structural and haemodynamic parameters in open-angle glaucoma patients</article-title>. <source>Acta Ophthalmol</source> <volume>86</volume>: <fpage>552</fpage>–<lpage>557</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Akarsu1"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Akarsu</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bilgili</surname><given-names>MY</given-names></name> (<year>2004</year>) <article-title>Color Doppler imaging in ocular hypertension and open-angle glaucoma</article-title>. <source>Graefes Arch Clin Exp Ophthalmol</source> <volume>242</volume>: <fpage>125</fpage>–<lpage>129</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Zhong1"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhong</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Min</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Qin</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Color Doppler imaging and pattern visual evoked potential in normal tension glaucoma and hypertension glaucoma</article-title>. <source>Doc Ophthalmol</source> <volume>119</volume>: <fpage>171</fpage>–<lpage>180</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Simsek1"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Simsek</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Yanik</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Conkbayir</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Zilelioglu</surname><given-names>O</given-names></name> (<year>2006</year>) <article-title>Comparative analysis of the effects of brimonidine and dorzolamide on ocular blood flow velocity in patients with newly diagnosed primary open-angle glaucoma</article-title>. <source>J Ocul Pharmacol Ther</source> <volume>22</volume>: <fpage>79</fpage>–<lpage>85</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Quigley1"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Quigley</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Broman</surname><given-names>AT</given-names></name> (<year>2006</year>) <article-title>The number of people with glaucoma worldwide in 2010 and 2020</article-title>. <source>Br J Ophthalmol</source> <volume>90</volume>: <fpage>262</fpage>–<lpage>267</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Hansen1"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hansen</surname><given-names>NB</given-names></name>, <name name-style="western"><surname>Stonestreet</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Rosenkrantz</surname><given-names>TS</given-names></name>, <name name-style="western"><surname>Oh</surname><given-names>W</given-names></name> (<year>1983</year>) <article-title>Validity of Doppler measurements of anterior cerebral artery blood flow velocity: correlation with brain blood flow in piglets</article-title>. <source>Pediatrics</source> <volume>72</volume>: <fpage>526</fpage>–<lpage>531</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Taylor1"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Taylor</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Short</surname><given-names>BL</given-names></name>, <name name-style="western"><surname>Walker</surname><given-names>LK</given-names></name>, <name name-style="western"><surname>Traystman</surname><given-names>RJ</given-names></name> (<year>1990</year>) <article-title>Intracranial blood flow: quantification with duplex Doppler and color Doppler flow US</article-title>. <source>Radiology</source> <volume>176</volume>: <fpage>231</fpage>–<lpage>236</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Platt1"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Platt</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Ellis</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Rubin</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>DiPietro</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Sedman</surname><given-names>AB</given-names></name> (<year>1990</year>) <article-title>Intrarenal arterial Doppler sonography in patients with nonobstructive renal disease: correlation of resistive index with biopsy findings</article-title>. <source>AJR Am J Roentgenol</source> <volume>154</volume>: <fpage>1223</fpage>–<lpage>1227</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Rifkin1"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rifkin</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Needleman</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Pasto</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Kurtz</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>Foy</surname><given-names>PM</given-names></name>, <etal>et al</etal>. (<year>1987</year>) <article-title>Evaluation of renal transplant rejection by duplex Doppler examination: value of the resistive index</article-title>. <source>AJR Am J Roentgenol</source> <volume>148</volume>: <fpage>759</fpage>–<lpage>762</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Brusini1"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brusini</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Zeppieri</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tosoni</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Parisi</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Felletti</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Stratus-OCT imaging in early glaucomatous and in ocular hypertensive patients with and without frequency-doubling technology abnormalities</article-title>. <source>Eye (Lond)</source> <volume>22</volume>: <fpage>406</fpage>–<lpage>413</lpage>.</mixed-citation></ref>
      <ref id="pone.0062723-Sihota1"><label>54</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sihota</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Sony</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Gupta</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Dada</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>R</given-names></name> (<year>2006</year>) <article-title>Diagnostic capability of optical coherence tomography in evaluating the degree of glaucomatous retinal nerve fiber damage</article-title>. <source>Invest Ophthalmol Vis Sci</source> <volume>47</volume>: <fpage>2006</fpage>–<lpage>2010</lpage>.</mixed-citation></ref>
   </ref-list>
</back>
</article>